Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.

Antimicrobial agents and chemotherapy - 1 Oct 2001

Livermore D M, Oakton K J, Carter M W, Warner M

Abstract excerpt

Ertapenem (MK-0826; L-749,345), a new carbapenem with a long serum half-life, was tested, in vitro, against beta-lactamase-producing bacteria. The new compound had a MIC at which 90% of the isolates were inhibited of 0.06 microg/ml for extended-spectrum beta-lactamase (ESBL)-producing klebsiellas, compared with 0.5 microg/ml for imipenem, 16 microg/ml for cefepime, and >128 microg/ml for ceftazidime and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Lactamases
Share to Carbapenems
Share to Enterobacteriaceae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bacterial Proteins

Share to Klebsiella

Share to Microbial Sensitivity Tests

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 11557477
DOI: 10.1128/AAC.45.10.2831-2837.2001
PMCID: PMC90739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.PMID 11557477Read ↗

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.Semantic proximity Read ↗

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.Semantic proximity Read ↗

Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.Semantic proximity Read ↗

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum beta-lactamase-producing Escherichia coli using an in vitro model.Semantic proximity Read ↗

Activities of doripenem (S-4661) against drug-resistant clinical pathogens.Semantic proximity Read ↗

Diverse Role of blaCTX-M and Porins in Mediating Ertapenem Resistance Among Carbapenem Resistant EnterobacteralesSemantic proximity Read ↗

Distinctive Features of Ertapenem-Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States: A Cohort StudySemantic proximity Read ↗

Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.